CAT No: CP25591
CAS No:205526-39-2
Synonyms/Alias:(S)-N-Fmoc-2-indanylglycine;205526-39-2;Fmoc-(2-indanyl)-Gly-OH;AmbotzFAA1697;PubChem23309;Fmoc-L-2-indanyglycine;Fmoc-L-2-indanylglycine;FMOC-GLY-OH;SCHEMBL120533;CTK8E9926;MolPort-002-344-049;ZINC2567694;6952AD;AKOS025312278;RTR-009604;AN-17256;TR-009604;A4468;FT-0679769;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-indan-2-yl-aceticacid;(S)-2,3-dihydro-1H-inden-2-yl({[(9H-fluoren-9-ylmethoxy)carbonyl]amino})aceticacid;(S)-2-(((9H-fluoren-9-yl)methoxy)carbonyl)-2-((S)-2,3-dihydro-1H-inden-1-yl)aceticacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-2-indanyl-L-glycine, (S)-2-(9-Fluorenylmethyloxycarbonylamino)-2-(2,3-dihydro-1H-inden-2-yl)acetic acid
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.